Medicare Enrolled

Dr. Dawn Merritt, D.O.

Dermatology · Athens, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2111 E STATE ST, Athens, OH 45701
7405665621
Registered in NPPES since 2007
NPI: 1750573986 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Merritt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Merritt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Merritt

Dr. Dawn Merritt is a dermatology specialist in Athens, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Merritt performed 1,566 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Merritt received a total of $846,646 from 46 pharmaceutical and/or device companies across 1254 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Merritt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 1,566 Medicare services $846,646 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,566
Medicare services
Bottom 42% in OH for dermatology
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
614 $5 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
377 $59 $131
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
186 $40 $96
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
126 $68 $147
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
115 $94 $185
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $37 $81
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
32 $37 $77
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
29 $226 $437
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
23 $94 $352
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
12 $126 $257
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $70 $163
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$846,646
Total received (2018-2024)
Avg $120,949/year across 7 years
Top 2% in OH for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,254
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$99,743
2023
$169,177
2022
$126,139
2021
$69,797
2020
$59,249
2019
$197,720
2018
$124,821

Payments by company (2024)

E.R. Squibb & Sons, L.L.C.
$21,962
Lilly USA, LLC
$16,806
ABBVIE INC.
$15,182
Dermavant Sciences, Inc.
$10,737
Novartis Pharmaceuticals Corporation
$6,699
SUN PHARMACEUTICAL INDUSTRIES INC.
$6,529
Arcutis Biotherapeutics, Inc.
$5,979
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,760
Ortho Dermatologics, a division of Bausch Health US, LLC
$3,748
UCB, Inc.
$2,977
Almirall LLC
$2,380
GENZYME CORPORATION
$2,240
Biofrontera Inc.
$392
Janssen Biotech, Inc.
$182
PFIZER INC.
$49
Chiesi USA, Inc.
$39
Incyte Corporation
$37
Amgen Inc.
$26
LEO Pharma Inc.
$18
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$183,165
Novartis Pharmaceuticals Corporation
$152,743
E.R. Squibb & Sons, L.L.C.
$85,898
AbbVie, Inc.
$59,772
ABBVIE INC.
$59,385
Celgene Corporation
$48,221
Dermavant Sciences, Inc.
$43,323
Janssen Scientific Affairs, LLC
$40,925
Sun Pharmaceutical Industries Inc.
$27,643
SUN PHARMACEUTICAL INDUSTRIES INC.
$27,207
PFIZER INC.
$20,549
Arcutis Biotherapeutics, Inc.
$20,273
Amgen Inc.
$15,150
UCB, Inc.
$13,848
NOVARTIS PHARMACEUTICALS CORPORATION
$10,950
AbbVie Inc.
$10,167
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,568
Ortho Dermatologics, a division of Bausch Health US, LLC
$6,312
Biofrontera Inc.
$3,926
GENZYME CORPORATION
$2,506
Almirall LLC
$2,396
LEO Pharma Inc.
$1,390
Janssen Biotech, Inc.
$1,218
Galderma Laboratories, L.P.
$307
Regeneron Healthcare Solutions, Inc.
$296
Genentech USA, Inc.
$217
Merz North America, Inc.
$216
Mayne Pharma Inc.
$189
MERZ NORTH AMERICA, INC.
$161
Incyte Corporation
$137
PruGen, Inc. Pharmaceuticals
$90
Eli Lilly and Company
$83
Merck Sharp & Dohme Corporation
$69
Bayer HealthCare Pharmaceuticals Inc.
$58
Mission Pharmacal Company
$49
DUSA Pharmaceuticals, Inc.
$40
Chiesi USA, Inc.
$39
SANOFI-AVENTIS U.S. LLC
$36
TARO PHARMACEUTICALS USA, INC.
$21
DERMIRA, INC.
$19
Aclaris Therapeutics, Inc.
$18
Taro Pharmaceuticals USA, Inc.
$15
Journey Medical Corporation
$15
Genentech, Inc.
$14
Allergan Inc.
$14
MAYNE PHARMA INC.
$11
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · AFINITOR · AKLIEF · AMELUZ · ARAZLO · Absorica LD · Ameluz · Avar · BF-RhodoLED · BLU-U · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cimzia · DERMATITIS - DISEASE · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EMGALITY · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FILSUVEZ · FINACEA · Finacea · HUMIRA · Humira · ILARIS · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · KEYTRUDA · Klisyri · LIBTAYO · ODOMZO · ODOMZO (sonidegib) capsules · OLUMIANT · OPZELURA · ORACEA · Olumiant · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOLODYN · SOOLANTRA · SPEVIGO · STELARA · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · VTAMA · Veltin · Winlevi · XEOMIN · Xeomin · Xolair · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Athens?
Compare dermatologists in the Athens area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
8
County median income
$53,837
Nearest hospital to ZIP centroid (approximate)
OHIOHEALTH O'BLENESS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Merritt is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Merritt experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Merritt performed 614 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Merritt receive payments from pharmaceutical companies?
Yes. Dr. Merritt received a total of $846,646 from 46 companies across 1,254 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Merritt's costs compare to other dermatologists in Athens?
Dr. Merritt's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Merritt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →